Pulmonary.aI

Pulmonary.aIPulmonary.aIPulmonary.aI
  • Home
  • About
  • Start here
  • Clinical Categories
  • Non-Clinical Categories
  • Seek insight
  • Contact Us
  • More
    • Home
    • About
    • Start here
    • Clinical Categories
    • Non-Clinical Categories
    • Seek insight
    • Contact Us

Pulmonary.aI

Pulmonary.aIPulmonary.aIPulmonary.aI
  • Home
  • About
  • Start here
  • Clinical Categories
  • Non-Clinical Categories
  • Seek insight
  • Contact Us

ILD

AI, mortality & ILD

2024_07


Computed tomography machine learning classifier correlates with mortality in interstitial lung disease


Moran-Mendoza et al.


https://pubmed.ncbi.nlm.nih.gov/38772191/


Highlights


A machine learning classifier system, Fibresolve, was designed and validated as an adjunct to non-invasive diagnosis in idiopathic pulmonary fibrosis (IPF). The system uses a deep learning algorithm to analyze chest computed tomography (CT) imaging. Fibresolve demonstrated to be an independent predictor of mortality in ILDs, with prognostic performance equivalent to GAP based solely on CT images.

AI, mortality & ILD

2024_05


Machine learning classifier is associated with mortality in interstitial lung disease: a retrospective validation study leveraging registry data


Selvan et al.


https://pubmed.ncbi.nlm.nih.gov/38783245/


Highlights


In this multi-center validation study, Fibresolve was applied to chest CT scans of patients with confirmed ILD that had available follow-up data. Fibresolve is independently associated with mortality in ILD, particularly amongst patients with non-IPF ILDs and in those with severe disease.


Copyright © 2025 Pulmonary.AI - All Rights Reserved.

Powered by

  • About
  • Start here
  • Clinical Categories
  • Non-Clinical Categories
  • Seek insight
  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept